Skip to main content

Magnolia Medical Steripath Micro Initial Specimen Diversion Device

Magnolia Medical Technologies launched its new Steripath Micro Initial Specimen Diversion Device, an FDA-cleared product indicated to reduce blood culture contamination. The device uses syringe-driven negative pressure to divert and sequester the first .6 to .9 mL of blood. The user then presses a button to isolate the diverted blood and a second blood flow pathway is opened to collect the blood specimen for culture in the syringe.